The Current Ratio as of September 2024 (TTM) for Regen BioPharma, Inc. (RGBP) is 0.03

According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.03. This represents a change of 9.92% compared to the average of 0.03 of the last 4 quarters.

Regen BioPharma, Inc. (RGBP) Historical Current Ratio (quarterly & annually)

How has RGBP Current Ratio performed in the past?

The mean historical Current Ratio of Regen BioPharma, Inc. over the last ten years is 0.08. The current 0.03 Current Ratio has changed 3.62% with respect to the historical average. Over the past ten years (40 quarters), RGBP's Current Ratio was at its highest in in the March 2015 quarter at 2.97. The Current Ratio was at its lowest in in the December 2019 quarter at 0.00.

Regen BioPharma, Inc. (RGBP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Regen BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regen BioPharma, Inc. (RGBP) Average Current Ratio

How has RGBP Current Ratio performed in the past?

The current Current Ratio of Regen BioPharma, Inc. (RGBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Regen BioPharma, Inc. (RGBP) Current Ratio vs. Peers

How is RGBP’s Current Ratio compared to its peers?

Regen BioPharma, Inc.’s Current Ratio is greater than Oncology Pharma Inc. (0), less than Propanc Biopharma, Inc. (0.03), greater than Kaleido Biosciences, Inc. (0), greater than RegeneRx Biopharmaceuticals, Inc. (0), less than Creative Medical Technology Holdings, Inc. (20.21), less than Theralink Technologies, Inc. (0.03), less than Enzolytics Inc. (0.98), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than PharmaTher Holdings Ltd. (0), less than Regen BioPharma, Inc. (10.60), less than Mymetics Corporation (0.03), greater than ProtoKinetix, Incorporated (0.00), less than Adynxx, Inc. (0.06), less than Ascletis Pharma Inc. (0), greater than Eupraxia Pharmaceuticals Inc. (0), less than AVAX Technologies, Inc. (16.58), less than null (1.95), less than null (1.61),

Build a custom stock screener for Regen BioPharma, Inc. (RGBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regen BioPharma, Inc. (RGBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.